Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2003
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2461213A1 Process for the preparation of citalopram
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/09/2003EP1300192A2 Shaped hydrogenation catalysts and processes for their preparation and use
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/09/2003EP1299118A2 Production and use of derivatized homoserine lactones
04/09/2003EP1299097A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
04/09/2003EP1299073A2 Agents for colouring keratin fibres, containing derivatives of benzo(b)furane-3-one and/or benzo(b)thiophene-3-one
04/09/2003EP1084115B1 Method for producing phthalic anhydride
04/09/2003EP1067995B1 Method for separating vaporous phthalic acid anhydride from a gas stream
04/09/2003EP1007519B1 Compounds for use in the treatment of cancer
04/09/2003EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
04/09/2003EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives
04/09/2003EP0793492B1 Use of sclareolide for treating disorders characterised by excessive cell proliferation
04/09/2003EP0789694B1 Method for preparing 8-alpha,12-oxido-13,14,15,16-tetranorlabdanum
04/09/2003EP0771197B1 Use of heterocyclic compounds as dopamines-d 3- ligands
04/09/2003CN1409653A Oxidative reaction using membrane that selectively conduct oxygen
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1104924C Thermally-managed separation and dewatering processes for recovering acid products
04/08/2003US6545167 Simple and effective manufacturing process for large scale recovery of Nimbin, a Neem seed constituent
04/08/2003US6545131 Tissue specific prodrug
04/08/2003US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa
04/08/2003US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc.
04/08/2003US6544974 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
04/08/2003CA2033190C N-phenylalkyl substituted alpha-amino carboxamide derivatives and process for their preparation
04/03/2003WO2003027090A2 Bicyclic heterocycles as rxr ligands
04/03/2003WO2003027089A1 Benzofuran, indole or benzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
04/03/2003WO2003027061A2 Muscarinic agonists
04/03/2003WO2003006450A3 Phthalide compounds useful in optical recording
04/03/2003WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
04/03/2003US20030065198 By hydrogenation
04/03/2003US20030065196 Method for resolving racemic mixtures of 5-substituted 4-hydroxy-2-furanones
04/03/2003US20030065194 Method for producing maleic acid anhydride
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065034 Antiinflammatory agents; coupling sulfonyl halide with aromatic amine compound
04/03/2003US20030064985 Prevent virus reproduction
04/03/2003US20030064977 Viricides
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/02/2003WO2002028821A2 Propionic acid derivatives with ppar-alpha activating properties
04/02/2003EP1298124A1 Method For the Preparation of Citalopram
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296970A1 Method for the preparation of citalopram
04/02/2003EP1296942A1 Glucagon antagonists/inverse agonists
04/02/2003EP1296940A1 Amidine derivatives as selective antagonists of nmda receptors
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296935A1 Process for the preparation of substituted octanoyl amides
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1296687A2 Treatment of male sexual dysfunction
04/02/2003EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
04/02/2003EP1140886B1 Method for the preparation of 5-cyanophthalide
04/02/2003EP1071677A4 Production of furanones
04/02/2003EP1027317B1 Reaction of alkenes with epoxides, the products thereof and their use as fragrance compounds
04/02/2003EP0956286B1 Synthesis of terfenadine and derivatives
04/02/2003EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1407982A Serotonergic benzofurans
04/02/2003CN1407981A Method for producing 5-(1piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
04/02/2003CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
04/02/2003CN1104413C Phenylalkylcarboxylic acid derivatives
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1104279C Preparation of o-phthalic acid anhydride and Ti-V-Cs contained coating catalyst
04/02/2003CA2424540A1 Propionic acid derivatives with ppar-alpha activating properties
04/01/2003US6541661 Inhibitors of histone deacetylase
04/01/2003US6541655 Catalytic compositions and methods for asymmetric allylic alkylation
04/01/2003US6541647 Methods of synthesis of substituted tetrahydrofuran compound
04/01/2003US6541646 Method of preparing COX-2 inhibitors
04/01/2003US6541506 Enediyne carboxylated on one end and having a pyrrole, furan or thiophene ring on the other; may be isolated from annarrhinum bellidofolium
04/01/2003US6541477 Inhibitors of p38-a kinase
04/01/2003US6541476 Piperazine derivatives and their use as anti-inflammatory agents
04/01/2003US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
04/01/2003US6541473 Resorcinol derivatives
04/01/2003US6540793 Coupler for use in oxidative hair dyeing
03/2003
03/28/2003WO2002030869A1 5-amino-1-pentene-3-ol substituted derivatives
03/28/2003CA2424103A1 Substituted 5-amino-1-penten-3-ol derivatives
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003WO2003024947A1 Process for preparing 2,5-diformylfuran from carbohydrates
03/27/2003WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060641 1-(4- fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile is reacted with 3-(N,N-dimethylamino)propyl-chloride in the presence of methylsulfinylmethide as condensing agent, oxidizing to form citalopram
03/27/2003US20030060640 Cyanation of 1-(4-fluorophenyl)-1,3-dihydroisobenzo-furan for producing antidepressant citalopram
03/27/2003US20030060638 C7 carbamate substituted taxanes
03/27/2003US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060460 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
03/27/2003US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 472